Anthony Markham

12.4k total citations
163 papers, 9.3k citations indexed

About

Anthony Markham is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anthony Markham has authored 163 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 32 papers in Physiology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anthony Markham's work include Asthma and respiratory diseases (13 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Anthony Markham is often cited by papers focused on Asthma and respiratory diseases (13 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Anthony Markham collaborates with scholars based in New Zealand, United Kingdom and United States. Anthony Markham's co-authors include Susan J. Keam, Diana Faulds, Karen L. Goa, Rachel H. Foster, Caroline M. Perry, Delyth Clemett, Michelle I. Wilde, Bret Fulton, Sean T. Duggan and Heather D. Langtry and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Anthony Markham

163 papers receiving 8.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Markham New Zealand 60 2.3k 1.8k 1.4k 1.0k 922 163 9.3k
Gillian M. Keating New Zealand 60 2.6k 1.1× 1.4k 0.8× 1.4k 1.0× 1.2k 1.2× 1.6k 1.7× 368 12.5k
Greg L. Plosker New Zealand 57 1.9k 0.8× 1.2k 0.7× 1.6k 1.1× 691 0.7× 1.0k 1.1× 261 10.1k
Lesley J. Scott New Zealand 57 3.1k 1.3× 1.6k 0.9× 1.6k 1.2× 1.2k 1.2× 1.6k 1.7× 333 12.9k
Diana Faulds New Zealand 63 2.0k 0.9× 1.5k 0.8× 1.5k 1.1× 1.0k 1.0× 1.6k 1.7× 122 10.4k
Susan J. Keam New Zealand 49 1.9k 0.8× 1.6k 0.9× 749 0.5× 877 0.9× 969 1.1× 211 7.3k
Satoru Takahashi Japan 56 4.0k 1.7× 1.7k 1.0× 1.9k 1.3× 2.6k 2.5× 927 1.0× 506 12.0k
Nadir Arber Israel 53 2.9k 1.3× 3.0k 1.7× 2.1k 1.5× 1.8k 1.7× 1.4k 1.6× 332 10.5k
Jingwen Zhang China 45 3.4k 1.5× 1.4k 0.8× 774 0.6× 985 1.0× 741 0.8× 296 7.7k
Mario Del Tacca Italy 48 2.4k 1.0× 2.7k 1.5× 1.2k 0.9× 1.1k 1.1× 645 0.7× 302 7.9k
Annalisa Santucci Italy 49 3.3k 1.4× 920 0.5× 1.2k 0.8× 1.0k 1.0× 814 0.9× 303 10.4k

Countries citing papers authored by Anthony Markham

Since Specialization
Citations

This map shows the geographic impact of Anthony Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Markham more than expected).

Fields of papers citing papers by Anthony Markham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Markham. The network helps show where Anthony Markham may publish in the future.

Co-authorship network of co-authors of Anthony Markham

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Markham. A scholar is included among the top collaborators of Anthony Markham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Markham. Anthony Markham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markham, Anthony. (2021). Mobocertinib: First Approval. Drugs. 81(17). 2069–2074. 50 indexed citations
2.
Markham, Anthony. (2021). Naxitamab: First Approval. Drugs. 81(2). 291–296. 57 indexed citations
3.
Markham, Anthony. (2021). Margetuximab: First Approval. Drugs. 81(5). 599–604. 41 indexed citations
4.
Markham, Anthony. (2020). Fostemsavir: First Approval. Drugs. 80(14). 1485–1490. 31 indexed citations
5.
Markham, Anthony. (2020). Belantamab Mafodotin: First Approval. Drugs. 80(15). 1607–1613. 111 indexed citations
6.
Markham, Anthony. (2020). Teprotumumab: First Approval. Drugs. 80(5). 509–512. 41 indexed citations
7.
Markham, Anthony. (2019). Alpelisib: First Global Approval. Drugs. 79(11). 1249–1253. 191 indexed citations
8.
Markham, Anthony. (2018). Tildrakizumab: First Global Approval. Drugs. 78(8). 845–849. 27 indexed citations
9.
Markham, Anthony. (2016). Brivaracetam: First Global Approval. Drugs. 76(4). 517–522. 19 indexed citations
10.
Markham, Anthony, et al.. (2014). Luseogliflozin: First Global Approval. Drugs. 74(8). 945–950. 82 indexed citations
11.
Prakash, Amitabh & Anthony Markham. (2000). Metoprolol. Drugs. 60(3). 647–678. 21 indexed citations
12.
Foster, Rachel H. & Anthony Markham. (2000). Levobupivacaine. Drugs. 59(3). 551–579. 290 indexed citations
13.
Gillis, Jane C. & Anthony Markham. (1999). Irbesartan. A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use in the Management of Hypertension. Arterial Hypertension. 3(1). 35–51. 3 indexed citations
14.
Markham, Anthony & Antona J. Wagstaff. (1998). Fexofenadine. Drugs. 55(2). 269–274. 92 indexed citations
15.
Wilde, Michelle I. & Anthony Markham. (1997). Danaparoid. Drugs. 54(6). 903–924. 81 indexed citations
16.
Dunn, Christopher J. & Anthony Markham. (1996). Epoetin Beta. Drugs. 51(2). 299–318. 23 indexed citations
17.
Pullen, R. G. L., et al.. (1995). Uptake of 75-selenium into the central nervous system of the rat. Neurochemical Research. 20(10). 1141–1146. 4 indexed citations
18.
Markham, Anthony & Harriet M. Bryson. (1995). Deflazacort. Drugs. 50(2). 317–333. 93 indexed citations
19.
Markham, Anthony & Eugene M. Sorkin. (1993). Ondansetron. Drugs. 45(6). 931–952. 76 indexed citations
20.
Markham, Anthony & Rex N. Brogden. (1993). Diltiazem. Drugs & Aging. 3(4). 363–390. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian M. Keating Breakdown of academic impact, for papers by Greg L. Plosker Breakdown of academic impact, for papers by Lesley J. Scott Breakdown of academic impact, for papers by Diana Faulds Breakdown of academic impact, for papers by Susan J. Keam Breakdown of academic impact, for papers by Satoru Takahashi Breakdown of academic impact, for papers by Nadir Arber Breakdown of academic impact, for papers by Jingwen Zhang Breakdown of academic impact, for papers by Mario Del Tacca Breakdown of academic impact, for papers by Annalisa Santucci
Rankless by CCL
2026